NORTHERN TERRITORY OF AUSTRALIA
MEDICINES, POISONS AND THERAPEUTIC GOODS ACT 2012
As in force at 10 December 2022
Table of provisions
NORTHERN TERRITORY OF
AUSTRALIA
____________________
As in force at 10 December 2022
____________________
MEDICINES, POISONS AND THERAPEUTIC GOODS ACT 2012
1 KEY
Key to abbreviations
amd = amended od =
order
app = appendix om =
omitted
bl = by-law pt =
Part
ch = Chapter r =
regulation/rule
cl = clause rem =
remainder
div = Division renum =
renumbered
exp = expires/expired rep
= repealed
f = forms s =
section
Gaz =
Gazette sch = Schedule
hdg =
heading sdiv = Subdivision
ins =
inserted SL = Subordinate
Legislation
lt = long title sub =
substituted
nc = not commenced
2 LIST OF LEGISLATION
Medicines, Poisons and Therapeutic Goods Act 2012 (Act No. 13, 2012) |
|
Assent date |
27 April 2012 |
Commenced |
|
Medicines, Poisons and Therapeutic Goods Amendment Act 2014 (Act No. 12, 2014) |
|
Assent date |
16 April 2014 |
Commenced |
16 April 2014 |
Correctional Services (Related and Consequential Amendments) Act 2014 (Act No. 27, 2014) |
|
Assent date |
4 September 2014 |
Commenced |
|
Statute Law Amendment (Directors' Liability) Act 2015 (Act No. 26, 2015) |
|
Assent date |
18 September 2015 |
Commenced |
14 October 2015 (Gaz G41, 14 October 2015, p 3) |
Local Court (Related Amendments) Act 2016 (Act No. 8, 2016) |
|
Assent date |
6 April 2016 |
Commenced |
1 May 2016 (s 2, s 2 Local Court (Repeals and Related Amendments) Act 2016 (Act No. 9, 2016) and Gaz S34, 29 April 2016) |
Justice Legislation Amendment (Drug Offences) Act 2016 (Act No. 17, 2016) |
|
Assent date |
8 June 2016 |
Commenced |
s 17 (to ext ins new s 15): 10 October 2016; rem: 18 July 2016 (Gaz S67, 18 July 2016) |
Statute Law Revision Act 2017 (Act No. 4, 2017) |
|
Assent date |
10 March 2017 |
Commenced |
12 April 2017 (Gaz G15, 12 April 2017, p 3) |
Health Practitioner Regulation (National Uniform Legislation) and Other Legislation Amendment Act 2018 (Act No. 28, 2018) |
|
Assent date |
30 November 2018 |
Commenced |
1 December 2018 (s 2) |
Medical Services Amendment Act 2019 (Act No. 17, 2019) |
|
Assent date |
30 May 2019 |
Commenced |
31 May 2019 (s 2) |
Hemp Industry Act 2019 (Act No. 25, 2019) |
|
Assent date |
2 September 2019 |
Commenced |
6 May 2020 (Gaz G18, 6 May 2020, p 2) |
Statute Law Revision Act 2020 (Act No. 26, 2020) |
|
Assent date |
19 November 2020 |
Commenced |
20 November 2020 (s 2) |
Medicines, Poisons and Therapeutic Goods Amendment Act 2021 (Act No. 1, 2021) |
|
Assent date |
25 February 2021 |
Commenced |
26 February 2021 (s 2) |
Medicines, Poisons and Therapeutic Goods Legislation Amendment Act 2021 (Act No. 27, 2021) |
|
Assent date |
15 December 2021 |
Commenced |
16 December 2021 (s 2) |
Medicines, Poisons and Therapeutic Goods Legislation Amendment Act 2022 (Act No. 25, 2022) |
|
Assent date |
9 December 2022 |
Commenced |
10 December 2022 (s 2) |
3 GENERAL AMENDMENTS
General amendments of a formal nature (which are not referred to in the table of amendments to this reprint) are made by the Interpretation Legislation Amendment Act 2018 (Act No. 22, 2018) to: ss 1, 5, 19, 24, 32, 43, 44, 80, 89, 92, 121, 125, 127, 128, 129, 183, 207, 232, 251, 252, 283 and 293.
4 LIST OF
AMENDMENTS
ss 3
– 4 amd No. 4, 2017, s 21
s 5 amd No. 12,
2014, s 3; No. 4, 2017, s 21; No. 28, 2018, s 12; No. 17, 2019, s 14; No.
1, 2021, s 4; No. 27, 2021, s 4; No. 25, 2022,
s 4
s 6 rep No. 4, 2017, s
20
s 7 amd No. 4, 2017, s
21
s 10 amd No. 25, 2022,
s 5
s 11 rep No. 25, 2022,
s 6
s 12 amd No. 4, 2017, s
21
s 13 rep No. 4, 2017, s
20
ch 1
pt
1.2, div 2
sdiv 3 hdg amd No. 4, 2017, s
21
s 17 amd No. 4, 2017, s
21
s 19 amd No. 12, 2014, s
4
s 20 amd No. 4, 2017, s
21
s 21 amd No. 4, 2017, s 21; No. 25, 2022,
s 7
s 22 amd No. 4, 2017, s
21
ch 1
pt
1.2, div 2
sdiv 4 hdg amd No. 4, 2017, s
21
s 23 amd No. 4, 2017, s
21
s 25 amd No. 25, 2022,
s 8
s 26 amd No. 12, 2014, s
5
s 25 amd No. 28, 2018, s 12; No. 27, 2021, s
11
s 28 sub No. 12, 2014, s
6
amd No. 25, 2022,
s 9
s 28A ins No. 12, 2014, s
6
sub No. 28, 2018, s
10
amd No. 25, 2022,
s 10
s 31 amd No. 4, 2017, s
21
s 31A ins No. 25, 2019, s
46
ss 32 – 33 amd No. 4, 2017, s
21
ch 2 hdg amd No. 4, 2017, s
21
s 34 amd No. 12, 2014, s 7; No. 4, 2017, s
21
s 35 amd No. 12, 2014, s 8; No. 4, 2017, s
21
ch 2
pt 2.2
hdg amd No. 4, 2017, s 21
ss 37 – 38 sub
No. 25, 2022, s 11
s 48 amd No. 25, 2022,
s 12
s 57 amd No. 4, 2017, s 21; No. 27,
2021, s 11
s 59A ins No. 12, 2014, s
9
s 61 amd No. 25, 2022,
s 54
s 62 sub No. 12, 2014, s
10
rep No. 25, 2022,
s 13
ch
2
pt 2.3, div
1
sdiv 3 hdg amd No. 25, 2022,
s 54
s 63 sub No. 12, 2014, s 11; No. 25,
2022, s 14
s 64 amd No. 28, 2018, s
12
sub No. 25, 2022,
s 14
s 65 amd No. 12, 2014, s
12
rep No. 25, 2022,
s 14
s 67 amd No. 12, 2014, s
13
rep No. 25, 2022,
s 15
ch
2
pt 2.3, div
1
sdiv 3A hdg ins No. 25, 2022,
s 16
s 70 rep No. 12, 2014, s
15
ins No. 25, 2022,
s 16
ss 70A – 70D ins No. 25, 2022,
s 16
ch
2
pt 2.3, div
1
sdiv 4 hdg amd No. 12, 2014, s
14
s 71 amd No. 12, 2014, s
16
sub No. 25, 2022,
s 17
s 72 amd No. 12, 2014, s
17
sub No. 25, 2022,
s 17
s 73 amd No. 4, 2017, s
21
s 75 sub No. 25, 2022,
s 18
s 78 amd No. 25, 2022,
s 19
ss 79 – 80 amd No. 4, 2017, s
21
s 81 amd No. 27, 2021, s
11
s 83 amd No. 27, 2021, s
11
s 84 amd No. 27, 2021, s 5; No. 25, 2022,
s 20
s 86 amd No. 4, 2017, s
21
s 92 amd No. 12, 2014, s 18; No. 25, 2022,
s 21
s 96 amd No. 27, 2021, s
6
pt 2.6 hdg amd No. 4, 2017, s
21
s. 98 amd No. 4, 2017, s
21
s 99 amd No. 12, 2014, s 19; No. 25, 2022,
s 22
s 100 amd No. 12, 2014, s
20
sub No. 25, 2022,
s 23
ch
2
pt 2.7 hdg amd No. 4, 2017, s
21
ss 101 – 105 amd No. 4, 2017, s
21
s 109 rep No. 12, 2014, s
21
s 110 amd No. 12, 2014, s
22
ch 2
pt
2.7
div 4A hdg ins No. 25, 2022,
s 24
ss 112A –
112C ins No. 25, 2022,
s 24
s 113 amd No. 4, 2017, s
21
ch 3 hdg amd No. 4, 2017, s
21
s 117 amd No. 25, 2022,
s 25
ss 118 – 119 amd No. 4, 2017, s
21
s 120 amd No. 25, 2022,
s 26
s 121 amd No. 17, 2016, s 46; No. 4,
2017, s 21
s 122 amd No. 4, 2017, s
21
s 122A ins No. 25, 2022,
s 27
s 123A ins No. 25, 2022,
s 28
s 127 amd No. 17, 2016, s
46
s 128 amd No. 17, 2016, s 46; No. 25, 2022,
s 29
s 129 amd No. 12, 2014, s 23; No. 17,
2016, s 46; No. 25, 2022, s 30
s 130 amd
No. 25, 2022, s 31
s 131 amd No. 25, 2022,
s 32
s 134 amd No. 4, 2017, s 21; No. 25,
2022, s 33
s 135 amd No. 4, 2017, s 21;
No. 25, 2022, s 34
s 136 amd No. 4, 2017,
s 21
s 136A ins No. 25, 2022,
s 35
s 140 sub No. 25, 2022,
s 36
s 141 and No. 25, 2022,
s 37
ss 142 – 143 amd No. 4, 2017, s
21
s 144 amd No. 12, 2014, s 24; No. 4, 2017, s
21
s 145A ins No. 25, 2022,
s 38
s 182 amd No. 8, 2016, s
45
s 193 amd No. 26, 2020, s
3
s 203 amd No. 4, 2017, s
21
s 206 amd No. 4, 2017, s
21
s 207 sub No. 27, 2021, s
7
s 215 amd No. 26, 2015, s
75
s 219 amd No. 4, 2017, s
21
s 230 amd No. 25, 2022,
s 39
ch
7
pt 7.1AA hdg ins No. 27, 2021, s
8
ch 7
pt
7.1AA
div 1 hdg ins No. 27, 2021, s
8
ss 243A –
243B ins No. 27, 2021, s
8
ch 7
pt
7.1AA
div 2 hdg ins No. 27, 2021, s
8
ss 243C –
243E ins No. 27, 2021, s
8
ch 7
pt
7.1AA
div 3 hdg ins No. 27, 2021, s
8
ss 243F –
243G ins No. 27, 2021, s
8
ch 7
pt
7.1AA
div 4 hdg ins No. 27, 2021, s
8
ss 243H –
243L ins No. 27, 2021, s
8
ch 7
pt
7.1AA
div 5 hdg ins No. 27, 2021, s
8
ss 243M –
243Q ins No. 27, 2021, s
8
s 244 amd No. 25, 2022,
s 40
ch
7
pt 7.2
div 1
hdg amd No. 4, 2017, s 21
s 245 amd No. 25,
2022, s 41
s 246 amd No. 25, 2022,
s 42
ss 247 – 248 rep No. 25, 2022,
s 43
s 249 amd No. 12, 2014, s
25
rep No. 25, 2022,
s 43
s 250 amd No. 12, 2014, s 26; No. 28,
2018, s 12
rep No. 25, 2022,
s 43
s 251 amd No. 4, 2017, s 21; No. 25,
2022, s 44
s 252 amd No. 27, 2014, s 57;
No. 25, 2022, s 45
s 253 amd No. 25, 2022,
s 46
s 254 amd No. 12, 2014, s 27; No. 28,
2018, s 11
sub No. 25, 2022,
s 47
ch
7
pt 7.2
div
1A hdg ins No. 1, 2021, s 5
rep No. 25, 2022,
s 48
ss 254A –
254C ins No. 1, 2021, s
5
rep No. 25, 2022,
s 48
s 257 amd No. 4, 2017, s 21; No. 25,
2022, s 49
s 261 amd No. 12, 2014, s
28
s 266 amd No. 25, 2022,
s 50
s 268 amd No. 25, 2022,
s 51
s 269 amd No. 25, 2022,
s 52
s 279 amd No. 4, 2017, s
21
s 281 amd No. 12, 2014, s 29; No. 4, 2017, s
21
s 283 amd No. 12, 2014, s 30; No. 4, 2017, s
21
s 294 exp No. 13, 2012, s
294(5)
ch 9
pt
9.3 hdg ins No. 26, 2015, s 76
s 295 exp No.
13, 2012, s 305
ins No. 26, 2015, s
76
ch 9
pt 9.4
hdg ins No. 27, 2021, s 9
ss 296 –
298 exp No. 13, 2012, s 305
ins No. 27, 2021,
s 9
ch 9
pt
9.5 hdg ins No. 25, 2022, s 53
ss 299
– 307 ins No. 25, 2022, s 53
ch 10
hdg exp No. 13, 2012, s 305
ch
10
pt 10.1 hdg exp No. 13, 2012, s
305
ss 299 – 303 exp No. 13, 2012, s
305
ch 10
pt
10.2 hdg exp No. 13, 2012, s 305
s 304 exp No.
13, 2012, s 305
ch
10
pt 10.3 hdg exp No. 13, 2012, s
305
s 305 exp No. 13, 2012, s
305
sch 1 amd No. 12, 2014, s
31
sch 2 amd No. 27, 2021, s
10
sch 4 exp No. 13, 2012, s
305